Assessment and management of neutralizing antibodies in patients with multiple sclerosis (Summary/Discussion)HARTUNG, Hans-Peter; MUNSCHAUER, Frederick E.Journal of neurology. Supplement. 2004, Vol 251, Num 2, pp 40-42, issn 0939-1517, 3 p.Article

Effects of /-amphetamine sulfate on cognitive function in multiple sclerosis patientsBENEDICT, Ralph H. B; MUNSCHAUER, Frederick; ZAREVICS, Peter et al.Journal of neurology. 2008, Vol 255, Num 6, pp 848-852, issn 0340-5354, 5 p.Article

Validity of the wisconsin card sorting and delis-kaplan executive function system (DKEFS) sorting tests in multiple sclerosisPARMENTER, Brett A; ZIVADINOY, Robert; KERENYI, Laura et al.Neuropsychology, development, and cognition. Section A, journal of clinical and experimental neuropsychology. 2007, Vol 29, Num 2, pp 215-223, issn 1380-3395, 9 p.Article

Reliable screening for neuropsychological impairment in multiple sclerosisBENEDICT, Ralph H. B; COX, Darcy; THOMPSON, Laetitia L et al.Multiple sclerosis. 2004, Vol 10, Num 6, pp 675-678, issn 1352-4585, 4 p.Article

Personality disorder in multiple sclerosis correlates with cognitive impairmentBENEDICT, Ralph H. B; PRIORE, Roger L; MILLER, Colleen et al.The Journal of neuropsychiatry and clinical neurosciences. 2001, Vol 13, Num 1, pp 70-76, issn 0895-0172Conference Paper

Plasma pentosidine: a potential biomarker in the management of multiple sclerosisSTERNBERG, Zohara; HENNIES, Cassandra; STERNBERG, Daniel et al.Multiple sclerosis. 2011, Vol 17, Num 2, pp 157-163, issn 1352-4585, 7 p.Article

Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patientsWEINSTOCK-GUTTMAN, Bianca; BAIER, Monika; AWAD, Atif B et al.Prostaglandins, leukotrienes and essential fatty acids. 2005, Vol 73, Num 5, pp 397-404, issn 0952-3278, 8 p.Article

Predicting quality of life in multiple sclerosis : accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior changeBENEDICT, Ralph H. B; WAHLIG, Elizabeth; BAKSHI, Rohit et al.Journal of the neurological sciences. 2005, Vol 231, Num 1-2, pp 29-34, issn 0022-510X, 6 p.Article

Frontal cortex atrophy predicts cognitive impairment in multiple sclerosisBENEDICT, Ralph H. B; BAKSHI, Rohit; SIMON, Jack H et al.The Journal of neuropsychiatry and clinical neurosciences. 2002, Vol 14, Num 1, pp 44-51, issn 0895-0172Article

Whole-brain atrophy in multiple sclerosis measured by automated versus Semiautomated MR imaging segmentationSHARMA, Jitendra; SANFILIPO, Michael P; BENEDICT, Ralph H. B et al.American journal of neuroradiology. 2004, Vol 25, Num 6, pp 985-996, issn 0195-6108, 12 p.Article

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensityBERMEL, Robert A; PULI, Srinivas R; RUDICK, Richard A et al.Archives of neurology (Chicago). 2005, Vol 62, Num 9, pp 1371-1376, issn 0003-9942, 6 p.Article

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trialMORROW, Sarah A; KAUSHIK, Tanya; ZAREVICS, Peter et al.Journal of neurology. 2009, Vol 256, Num 7, pp 1095-1102, issn 0340-5354, 8 p.Article

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosisBENEDICT, Ralph H. B; BRACE, Jared; DWYER, Michael G et al.Multiple sclerosis. 2007, Vol 13, Num 6, pp 722-730, issn 1352-4585, 9 p.Article

MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosisSTOSIC, Milena; AMBRUS, Julian; BAKSHI, Rohit et al.Journal of neurology. 2010, Vol 257, Num 1, pp 63-71, issn 0340-5354, 9 p.Article

Cortical Atrophy and Personality in Multiple SclerosisBENEDICT, Ralph H. B; HUSSEIN, Sarah; ENGLERT, Jessica et al.Neuropsychology. 2008, Vol 22, Num 4, pp 432-441, issn 0894-4105, 10 p.Article

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosisPHILLIPS, J. Theodore; GIOVANNONI, Gavin; LUBLIN, Fred D et al.Multiple sclerosis. 2011, Vol 17, Num 8, pp 970-979, issn 1352-4585, 10 p.Article

Eight-year immunogenicity and safety of interferon beta-la-avonex® treatment in patients with multiple sclerosisHERNDON, Robert M; RUDICK, Richard A; GOODKIN, Donald et al.Multiple sclerosis. 2005, Vol 11, Num 4, pp 409-419, issn 1352-4585, 11 p.Article